
Abstract
The members of the Wnt glycoprotein family are important in embryogenesis and adult tissue homeostasis, and deletion of Wnt-4 gene in mice leads to improper development of many organs including the adrenals. The objective of this study was to investigate the expression of WNT-4 gene in human adrenals and adrenocortical tumors. The WNT-4 mRNA expression (analyzed by quantitative real-time RT-PCR) was significantly higher in Conn's adenomas (p<0.01) and lower in Cushing's adenomas, virilizing carcinomas and fetal adrenals (p<0.05) compared with normal adult adrenals. WNT-4 mRNA expression was clearly upregulated by ACTH and 8-bromo-cAMP (8-BrcAMP) in primary cultures of normal adult adrenocortical cells, but downregulated by 8-BrcAMP and 12-O-tetradecanoylphorbol-13-acetate (TPA) in human NCI-H295R adrenocortical carcinoma cells. Angiotensin II tended to increase WNT-4 mRNA expression at 24 hours and decreased it at 48 hours time point in both cell culture types. The abundant WNT-4 mRNA expression in Conn's adenomas and its hormonal regulation in adrenocortical cells suggest a role for WNT-4 in human adrenocortical function.
Key words
WNT-4 - adrenal glands - β-catenin - adrenal cortex - neoplasms (human)
References
-
1
Logan CY, Nusse R.
The Wnt signaling pathway in development and disease.
Annu Rev Cell Dev Biol.
2004;
20
781-810
-
2
Dale TC.
Signal transduction by the Wnt family of ligands.
Biochem J.
1998;
329
209-223
-
3
Kawano Y, Kypta R.
Secreted antagonists of the Wnt signalling pathway.
J Cell Sci.
2003;
116
2627-2634
-
4
Huelsken J, Behrens J.
The Wnt signalling pathway.
J Cell Sci.
2002;
115
3977-3978
-
5
Miller JR.
The Wnts.
Genome Biol.
2002;
3
, reviews 3001.1–3001.15
-
6
Moon RT, Kohn AD, Ferrari GV De, Kaykas A.
WNT and beta-catenin signalling: diseases and therapies.
Nat Rev Genet.
2004;
5
691-701
-
7
Vainio S, Heikkilä M, Kispert A, Chin N, MacMahon AP.
Female development in mammals is regulated by Wnt-4 signalling.
Nature.
1999;
397
405-409
-
8
Bernard P, Harley VR.
Wnt4 action in gonadal development and sex determination.
Int J Biochem Cell Biol.
2007;
39
31-43
-
9
Mizusaki H, Kawabe K, Mukai T, Ariyoshi E, Kasahara M, Yoshioka H, Swain A, Morohashi K.
Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad.
Mol Endocrinol.
2003;
17
507-519
-
10
Heikkilä M, Prunskaite R, Naillat F, Itäranta P, Vuoristo J, Leppäluoto J, Peltoketo H, Vainio S.
The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action.
Endocrinology.
2005;
146
4016-4023
-
11
Jordan BK, Shen JH, Olaso R, Ingraham HA, Vilain E.
Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy.
Proc Natl Acad Sci USA.
2003;
100
10866-10871
-
12
Jeays-Ward K, Dandonneau M, Swain A.
Wnt4 is required for proper male as well as female sexual development.
Dev Biol.
2004;
276
431-440
-
13
Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, Dewing P, Swain A, Rao PN, Elejalde BR, Vilain E.
Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.
Am J Hum Genet.
2001;
68
1102-1109
-
14
Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ.
A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman.
N Engl J Med.
2004;
351
792-798
-
15
Suwa T, Chen M, Hawks CL, Hornsby PJ.
Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex.
J Endocrinol.
2003;
178
149-158
-
16
Peltoketo H, Allinen M, Vuosku J, Kujala S, Lundan T, Salminen A, Winqvist R, Vainio S.
Characterization and expression of the human WNT4; lack of associated germline mutations in high-to moderate-risk breast and ovarian cancer.
Cancer Lett.
2004;
213
83-90
-
17
Heikkilä M, Peltoketo H, Leppäluoto J, Ilves M, Vuolteenaho O, Vainio S.
Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production.
Endocrinology.
2002;
143
4358-4365
-
18
Arola J, Liu J, Heikkilä P, Ilvesmäki V, Salmenkivi K, Voutilainen R, Kahri AI.
Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
J Endocrinol.
2000;
165
223-229
-
19
Voutilainen R, Erämaa M, Ritvos O.
Hormonally regulated inhibin gene expression in human fetal and adult adrenals.
J Clin Endocrinol Metab.
1991;
73
1026-1030
-
20
Vänttinen T, Kuulasmaa T, Liu J, Voutilainen R.
Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells.
J Clin Endocrinol Metab.
2002;
87
4257-4263
-
21
Utriainen P, Liu J, Kuulasmaa T, Voutilainen R.
Inhibition of DNA methylation increases follistatin expression and secretion in the human adrenocortical cell line NCI-H295R.
J Endocrinol.
2006;
188
305-310
-
22
Eberhart CG, Argani P.
Wnt signaling in human development: beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage.
Pediatr Dev Pathol.
2001;
4
351-357
-
23
Lyons JP, Mueller UW, Ji H, Everett C, Fang X, Hsieh JC, Barth AM, McCrea PD.
Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells.
Exp Cell Res.
2004;
298
369-387
-
24
Hou X, Tan Y, Li M, Dey SK, Das SK.
Canonical Wnt signaling is critical to estrogen-mediated uterine growth.
Mol Endocrinol.
2004;
18
3035-3049
-
25
Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere AM, Rene-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J.
Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Cancer Res.
2005;
65
7622-7627
-
26
Chen M, Hornsby PJ.
Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells.
Horm Metab Res.
2006;
38
549-555
Correspondence
R. Voutilainen
Department of Pediatrics
Kuopio University Hospital
P.O. Box 1777
70211 Kuopio
Finland
Phone: +358/17/17 23 91
Fax: +358/17/17 24 10
Email: Raimo.Voutilainen@uku.fi